Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2014 | 11-2013 | 11-2012 | 11-2011 | 11-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,483 | 4,893 | 5,254 | 9,005 | 8,570 |
| Marketable Securities | 103 | 38 | N/A | 1,002 | 1,132 |
| Receivables | 4,072 | 3,337 | 2,837 | 3,059 | 2,356 |
| Inventories | 64 | N/A | N/A | N/A | N/A |
| Income taxes - deferred | N/A | N/A | N/A | 210 | 168 |
| Other current assets | 59 | 706 | 565 | 0 | 0 |
| TOTAL | $8,492 | $9,463 | $9,315 | $14,053 | $12,873 |
| Non-Current Assets | |||||
| PPE Net | 953 | 1,207 | 1,281 | 1,540 | 2,222 |
| Investments And Advances | 684 | 684 | 698 | 690 | 690 |
| Intangibles | 28 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 52 | 146 | 1,037 | 3,183 | 2,307 |
| TOTAL | $1,718 | $2,037 | $3,016 | $5,413 | $5,220 |
| Total Assets | $10,210 | $11,501 | $12,331 | $19,467 | $18,093 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 993 | 1,195 | 1,210 | 1,005 | 1,053 |
| Accrued Expenses | 1,472 | 1,801 | 2,918 | 2,317 | 1,621 |
| Other current liabilities | N/A | N/A | N/A | 900 | N/A |
| TOTAL | $9,127 | $9,810 | $10,664 | $10,564 | $8,258 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,663 | 6,815 | 6,536 | 6,341 | 5,583 |
| Other Non-Current Liabilities | 2,300 | 2,300 | 2,300 | 2,850 | 3,750 |
| TOTAL | $11,809 | $10,958 | $10,665 | $11,364 | $10,837 |
| Total Liabilities | $20,936 | $20,769 | $21,328 | $21,927 | $19,095 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,002 | 10,683 | 10,985 | 11,853 | 11,753 |
| Common Shares | 119 | 119 | 119 | 119 | 118 |
| Retained earnings | -33,575 | -33,726 | -33,753 | -27,445 | -25,349 |
| Other shareholders' equity | -113 | 74 | -188 | -485 | -579 |
| TOTAL | $-10,727 | $-9,268 | $-8,998 | $-2,460 | $-1,002 |
| Total Liabilities And Equity | $10,210 | $11,501 | $12,331 | $19,467 | $18,093 |